What's happening at Agathisha

Our longest-running dataset — 1,240 patients followed for up to a decade — has been published in full. The headline finding is less dramatic than the field would like: durable benefit is real but modest, highly dependent on indication, and strongly influenced by donor variability.

We have released the de-identified dataset alongside the paper so other groups can test their own hypotheses against it.